NO903389D0 - Fremgangsmaate for fremstilling av 1,3-dihydro-1-(pyridinylamino)-2h-indol-2-oner, samt anvendelse som medikamenter. - Google Patents
Fremgangsmaate for fremstilling av 1,3-dihydro-1-(pyridinylamino)-2h-indol-2-oner, samt anvendelse som medikamenter.Info
- Publication number
- NO903389D0 NO903389D0 NO903389A NO903389A NO903389D0 NO 903389 D0 NO903389 D0 NO 903389D0 NO 903389 A NO903389 A NO 903389A NO 903389 A NO903389 A NO 903389A NO 903389 D0 NO903389 D0 NO 903389D0
- Authority
- NO
- Norway
- Prior art keywords
- pyridinylamino
- indol
- dihydro
- preparation
- loweralkyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
- C07D209/32—Oxygen atoms
- C07D209/34—Oxygen atoms in position 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/56—Ring systems containing three or more rings
- C07D209/96—Spiro-condensed ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/10—Spiro-condensed systems
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Indole Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US07/388,437 US5006537A (en) | 1989-08-02 | 1989-08-02 | 1,3-dihydro-1-(pyridinylamino)-2H-indol-2-ones |
| US07/535,640 US5053511A (en) | 1989-08-02 | 1990-06-11 | 1,3-dihydro-1-(pyridinylamino)-2h-indol-2-ones |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO903389D0 true NO903389D0 (no) | 1990-08-01 |
| NO903389L NO903389L (no) | 1991-02-04 |
Family
ID=27012314
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO90903389A NO903389L (no) | 1989-08-02 | 1990-08-01 | Fremgangsmaate for fremstilling av 1,3-dihydro-1-(pyridinylamino)-2h-indol-2-oner, samt anvendelse som medikamenter. |
Country Status (18)
| Country | Link |
|---|---|
| US (2) | US5006537A (no) |
| EP (1) | EP0415102B1 (no) |
| JP (1) | JPH0674265B2 (no) |
| KR (2) | KR0169108B1 (no) |
| AT (1) | ATE118001T1 (no) |
| AU (2) | AU628202B2 (no) |
| CA (1) | CA2022486C (no) |
| DE (1) | DE69016530T2 (no) |
| DK (1) | DK0415102T3 (no) |
| ES (1) | ES2068293T3 (no) |
| FI (1) | FI903819A0 (no) |
| GR (1) | GR3015227T3 (no) |
| IE (1) | IE67045B1 (no) |
| IL (1) | IL95252A0 (no) |
| NO (1) | NO903389L (no) |
| NZ (1) | NZ234725A (no) |
| PT (1) | PT94879B (no) |
| ZA (1) | ZA906050B (no) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4868190A (en) * | 1988-12-27 | 1989-09-19 | Hoechst-Roussel Pharmaceuticals, Inc. | N-pyridinyl-9H-carbazol-9-amines |
| US5296488A (en) * | 1989-08-02 | 1994-03-22 | Hoechst-Roussel Pharmaceuticals Inc. | Method of using 2,3-dihydro-1-(pyridinylamino)-indoles as anticonvulsants and for the enhancement of memory |
| US5006537A (en) * | 1989-08-02 | 1991-04-09 | Hoechst-Roussel Pharmaceuticals, Inc. | 1,3-dihydro-1-(pyridinylamino)-2H-indol-2-ones |
| US4914102A (en) * | 1989-09-28 | 1990-04-03 | Hoechst Roussel Pharmaceuticals, Inc. | N-aminocarbamates related to physostigmine, pharmacentical compositions and use |
| US5076835A (en) * | 1990-05-31 | 1991-12-31 | America Cyanamid Company | Aryloxyspiroalkylindolinone herbicides |
| US5102891A (en) * | 1990-07-23 | 1992-04-07 | Hoechst-Roussel Pharmaceuticals Inc. | 1-(substituted pyridinylamino)-1H-indol-5-yl substituted carbamates |
| US5264442A (en) * | 1990-08-13 | 1993-11-23 | Hoechst-Roussel Pharmaceuticals Incorporated | Carbamoyl-1-(pyridinylalkyl)-1H-indoles, indolines and related analogs |
| US5214038A (en) * | 1991-04-15 | 1993-05-25 | Hoechst-Roussel Pharmaceuticals Inc. | 1-(pyrido[3,4-b]-1,4-oxazinyl-4-yl)-1H-indoles and intermediates for the preparation thereof |
| US5185350A (en) * | 1991-09-23 | 1993-02-09 | Hoechst-Roussel Pharmaceuticals Incorporated | Substituted pyridinylamino-1h-indoles,1h-indazoles,2h-indazoles, benzo (b)thiophenes and 1,2-benzisothiazoles |
| US5246947A (en) * | 1991-09-23 | 1993-09-21 | Hoechst-Roussel Pharmaceuticals Incorporated | Substituted pyridinylamino-1,2-benzisothiazoles and their use for treating depression |
| AU3425493A (en) * | 1992-01-16 | 1993-08-03 | Du Pont Merck Pharmaceutical Company, The | Novel neurotransmitter releasers useful for cognition enhancement |
| RU2051151C1 (ru) * | 1992-01-16 | 1995-12-27 | Дзе Дюпон Мерк Фармасьютикал Компани | Азотсодержащие гетероциклические производные флуорена |
| US5278162A (en) * | 1992-09-18 | 1994-01-11 | The Du Pont Merck Pharmaceutical Company | 3,3'-disubstituted-1,3-dihydro-2H-pyrrolo[2,3-b]heterocyclic-2-one useful in the treatment of cognitive disorders of man |
| US5296478A (en) * | 1992-10-07 | 1994-03-22 | The Dupont Merck Pharmaceutical Co. | 1-substituted oxindoles as cognition enhancers |
| FR2708606B1 (fr) * | 1993-07-30 | 1995-10-27 | Sanofi Sa | Dérivés du N-phénylalkylindol-2-one, leur préparation, les compositions pharmaceutiques en contenant. |
| AU1884595A (en) * | 1994-04-29 | 1995-11-29 | Pfizer Inc. | Novel acyclic and cyclic amides as neurotransmitter release enhancers |
| HUP9802413A3 (en) * | 1995-07-27 | 2002-02-28 | Aventis Pharmaceuticals Inc Br | Use of n-(pyrrol-1-yl)pyridinamines as anticonvulsant agents and for the preparation of a pharmaceutical composition for the treatment of convulsions |
| US6100276A (en) * | 1996-04-12 | 2000-08-08 | Aventis Pharmaceuticals Inc. | Isatin derivatives as acetylcholinesterase inhibitors and analgesics |
| IL126308A0 (en) * | 1996-04-12 | 1999-05-09 | Hoechst Marion Roussel Inc | Isatin derivatives as acetylcholinesterase inhibitors and analgesics |
| JP4256937B2 (ja) * | 1996-12-27 | 2009-04-22 | アベンティス・ファーマスーティカルズ・インコーポレイテッド | Ｎ−（ピリジニルアミノ）イソインドリン類および関連化合物 |
| KR100507145B1 (ko) * | 2002-06-20 | 2005-08-09 | 현대자동차주식회사 | 차량의 전원제어장치 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4260767A (en) * | 1979-12-26 | 1981-04-07 | American Cyanamid Company | 2-Pyridylhydrazides |
| US4569942A (en) * | 1984-05-04 | 1986-02-11 | Pfizer Inc. | N,3-Disubstituted 2-oxindole-1-carboxamides as analgesic and antiinflammatory agents |
| DE3852335T2 (de) * | 1987-04-24 | 1995-05-11 | Hoechst Roussel Pharma | N-(Pyridinyl)-1H-indol-1-amine, Verfahren zu deren Herstellung und ihre Verwendung als Arzneimittel. |
| US4983615A (en) * | 1989-06-28 | 1991-01-08 | Hoechst-Roussel Pharmaceuticals Inc. | Heteroarylamino- and heteroaryloxypyridinamine compounds which are useful in treating skin disorders |
| US5006537A (en) * | 1989-08-02 | 1991-04-09 | Hoechst-Roussel Pharmaceuticals, Inc. | 1,3-dihydro-1-(pyridinylamino)-2H-indol-2-ones |
-
1989
- 1989-08-02 US US07/388,437 patent/US5006537A/en not_active Expired - Lifetime
-
1990
- 1990-06-11 US US07/535,640 patent/US5053511A/en not_active Expired - Lifetime
- 1990-07-31 IL IL95252A patent/IL95252A0/xx active IP Right Grant
- 1990-07-31 AT AT90114660T patent/ATE118001T1/de not_active IP Right Cessation
- 1990-07-31 EP EP90114660A patent/EP0415102B1/en not_active Expired - Lifetime
- 1990-07-31 DE DE69016530T patent/DE69016530T2/de not_active Expired - Lifetime
- 1990-07-31 ES ES90114660T patent/ES2068293T3/es not_active Expired - Lifetime
- 1990-07-31 FI FI903819A patent/FI903819A0/fi not_active Application Discontinuation
- 1990-07-31 DK DK90114660.5T patent/DK0415102T3/da active
- 1990-07-31 NZ NZ234725A patent/NZ234725A/xx unknown
- 1990-08-01 IE IE278790A patent/IE67045B1/en not_active IP Right Cessation
- 1990-08-01 ZA ZA906050A patent/ZA906050B/xx unknown
- 1990-08-01 CA CA002022486A patent/CA2022486C/en not_active Expired - Lifetime
- 1990-08-01 JP JP2202618A patent/JPH0674265B2/ja not_active Expired - Lifetime
- 1990-08-01 PT PT94879A patent/PT94879B/pt not_active IP Right Cessation
- 1990-08-01 AU AU60004/90A patent/AU628202B2/en not_active Ceased
- 1990-08-01 NO NO90903389A patent/NO903389L/no unknown
- 1990-08-01 KR KR1019900011818A patent/KR0169108B1/ko not_active IP Right Cessation
-
1992
- 1992-07-14 AU AU19630/92A patent/AU641595B2/en not_active Expired - Fee Related
-
1995
- 1995-02-28 GR GR950400432T patent/GR3015227T3/el unknown
-
1998
- 1998-06-26 KR KR1019980024262A patent/KR0175639B1/ko not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| GR3015227T3 (en) | 1995-05-31 |
| PT94879A (pt) | 1991-04-18 |
| ES2068293T3 (es) | 1995-04-16 |
| ATE118001T1 (de) | 1995-02-15 |
| US5006537A (en) | 1991-04-09 |
| IE902787A1 (en) | 1991-02-27 |
| CA2022486C (en) | 2001-04-03 |
| IL95252A0 (en) | 1991-06-10 |
| JPH0674265B2 (ja) | 1994-09-21 |
| PT94879B (pt) | 1997-08-29 |
| KR910004599A (ko) | 1991-03-29 |
| AU641595B2 (en) | 1993-09-23 |
| JPH03118377A (ja) | 1991-05-20 |
| AU1963092A (en) | 1992-10-01 |
| CA2022486A1 (en) | 1991-02-03 |
| KR0175639B1 (en) | 1999-10-01 |
| ZA906050B (en) | 1991-05-29 |
| DK0415102T3 (da) | 1995-06-19 |
| EP0415102A1 (en) | 1991-03-06 |
| AU6000490A (en) | 1991-02-07 |
| DE69016530D1 (de) | 1995-03-16 |
| DE69016530T2 (de) | 1995-07-06 |
| US5053511A (en) | 1991-10-01 |
| FI903819A0 (fi) | 1990-07-31 |
| AU628202B2 (en) | 1992-09-10 |
| NZ234725A (en) | 1992-12-23 |
| EP0415102B1 (en) | 1995-02-01 |
| KR0169108B1 (ko) | 1999-01-15 |
| NO903389L (no) | 1991-02-04 |
| IE67045B1 (en) | 1996-02-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO903389L (no) | Fremgangsmaate for fremstilling av 1,3-dihydro-1-(pyridinylamino)-2h-indol-2-oner, samt anvendelse som medikamenter. | |
| EP0417584A3 (en) | N-substituted-4-pyrimidinamines and -pyrimidindiamines, a process for their preparation and their use as medicaments | |
| NO903388L (no) | Fremgangsmaate for fremstilling av 1-(pyridinylamino)-2-pyrrolidinoner, samt anvendelse som medikamenter. | |
| AU628201B2 (en) | 2,3-dihydro-1-(pyridinylamino)-indoles, a process for their preparation and their use as medicaments | |
| PT92234A (pt) | Processo para a preparacao de 1,2,3,4-tetraidro-1,9-acridinodiaminas |